DeSantis government touches on monoclonal antibody treatment by keeping hospital prices up – news Miami

DeSantis government touches on monoclonal antibody treatment by keeping hospital prices up - news Miami

READ MORE: Tri-Rail Almost Back To Full Service, With More Options For Commuters

They are used for many different kinds of diseases, including autoimmune diseases from Crohn’s disease to psoriasis and cancer therapy, according to FIU infectious disease specialist Dr. Aileen Marty. In terms of COVID-19, there are more than 40 different companies and varieties of monoclonal antibodies that different groups have developed to try and prevent disease from COVID-19.

READ MORE: Miami Commission Meets Thursday To Decide Whether Termination Of Police Chief Art Acevedo Moves Forward

Gov. DeSantis says monoclonal antibodies have “saved thousands upon thousands upon thousands of people from having to be admitted into the hospital and there’s no question we’ve saved many lives as a result making these treatments accessible to people.”

Story Highlights

  • “There were a lot that didn’t know about the monoclonal antibodies that were available, so we went around, made sure to raise the recognition but also wanted to increase access so we ended up setting up 25 different sites throughout the state of Florida,” said DeSantis at a news conference in Fort Myers. “We’ve now done I think 135,000 treatments of individuals throughout the state since the middle of August and this is something that filled a huge need and really the results speak for themselves. Since we established our monoclonal antibody program in the middle of August, the 7-day average of hospital admissions has fallen over 50 consecutive days. It’s now fallen over 80%. These are the daily people that are going in, clearly the whole purpose of these monoclonals is keep people out of the hospital let them recover.”

  • Monoclonal antibodies are man-made proteins that act like human antibodies in the immune system to fight off harmful pathogens such as viruses.

Monoclonal antibodies are administered for the treatment of mild to moderate COVID-19 in adults and pediatric patients (12 years of age or older), and who are at high risk for progressing to severe COVID-19. This includes those who are 65 years or older who have certain chronic medical conditions. High risk patients include the those who are elderly, immunocompromised, morbidly obese, suffer from heart disease, chronic kidney disease, lung conditions and sickle cell.

“And clearly people that have been vaccinated utilize these therapies at really equal levels to people who are not vaccinated and at many of our sites there’s way more people that are vaccinated on a daily basis who are coming in COVID positive and getting the monoclonal antibody treatment, so I think it’s important across the board and I think it’s something that really made a big difference and it is treatable.”

The first monoclonal antibody used in Florida was Regeneron. However, the state started purchasing Sotrovimab directly from the pharmaceutical company GlaxoSmithKline after the federal government took control of distribution of COVID-19 treatments produced by other companies. To find a monoclonal antibody treatment site near you, visit to make an appointment.

MORE NEWS: Hispanic Heritage Month Celebrated Daily At Local Quinceceañera Event Shop More information and a map of other monoclonal antibody sites is available at You can also call 850-344-9637.